Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating the Efficacy and Safety of Favipiravir in Adult Subjects With Uncomplicated Influenza (T705US316)

NCT02026349 is registered in ClinicalTrials.gov with MDVI, LLC as lead sponsor.

NCT NCT02026349
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02026349 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating the Efficacy and Safety of Favipiravir in Adult Subjects With Uncomplicated Influenza (T705US316)
Lead sponsor
MDVI, LLC
Phase
Phase 3
Overall status
Completed
Start date
January 31, 2014
Completion date
March 31, 2015
Enrollment
860 (actual)
Sites
225

Conditions

As the registry lists them; a condition with its own page is linked.

influenza